2014 Issues

VA Slammed for Slow Action Against Officials Behind Wait-Time Scandal

VA Slammed for Slow Action Against Officials Behind Wait-Time Scandal

Legislators: Only Four Senior Executives Removed by Mid-November

VA Launches Largest Overhaul Ever as McDonald Pushes Reforms

VA Launches Largest Overhaul Ever as McDonald Pushes Reforms

WASHINGTON – New VA Secretary Robert McDonald continues to methodically tackle the issues that have caused a breakdown in efficient veteran care over the last few years, now pushing the agency to undertake the largest reorganization since its founding.

VA’s IT Security Controls Cited for 15th Year in a Row

VA’s IT Security Controls Cited for 15th Year in a Row

Controversial Scheduling System Will Be Replaced in 2015

Study Offers New Statistics on How Many OEF/OIF Veterans Have PTSD

Condition Not Just Related to Deployment By Brenda L. Mooney WASHINGTON – While many studies have reported the prevalence of post-traumatic stress disorder (PTSD) in Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) veterans, most of the past research has… Read More

Danger of Pneumonia Increases with Veterans’ Worsened Health Status

Danger of Pneumonia Increases with Veterans’ Worsened Health Status

Higher Pneumonia Vaccine Rates Urged By Brenda L. Mooney PROVIDENCE, RI – With influenza season each year comes an even greater challenge for VA hospitals — a spate of pneumonia cases in older veterans. Recent research suggests the problem will… Read More

Partnerships, Drive-Throughs Seek to Increase Veterans’ Flu Immunization

Partnerships, Drive-Throughs Seek to Increase Veterans’ Flu Immunization

Free Shots Available at Walgreen’s Locations By Annette M. Boyle SAN FRANCISCO – The VA typically has influenza vaccination rates well above the national average but is trying some innovative measures to do even better. As part of the effort to increase immunizations,… Read More

FDA Approves New Abuse-Deterrent Opioid Analgesic

STAMFORD, CT – A new abuse-deterrent opioid analgesic has been approved by the Food and Drug Administration. Hysingla ER (hydrocodone bitartrate) is an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and… Read More

FDA Plans Review of Study on Death Risk with Dual Blood Thinners

WASHINGTON – A clinical trial showing that treatment for 30 months with dual antiplatelet blood-thinning therapy decreased the risk of heart attacks and clot formation in stents, but there was an increased overall risk of death compared to 12 months… Read More

Non-Invasive Technique to Evaluate Arterial Blood Flow Gets OK

REDWOOD CITY, CA – New software has been approved for marketing by the Food and Drug Administration  and is designed to help healthcare professionals evaluate patients showing signs and symptoms of coronary artery disease.  The product, HeartFlow FFR-CT software, permits… Read More

Newly Approved Meningococcal Vaccine Offers More Coverage

PHILADELPHIA – The first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age has been approved by the Food and Drug Administration. Vaccination is… Read More